- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
452
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
452 companies
4D Molecular Therapeutics
Market Cap: US$190.3m
A clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States.
FDMT
US$4.18
7D
7.3%
1Y
-86.5%
Silence Therapeutics
Market Cap: US$184.6m
A biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$3.90
7D
-13.3%
1Y
-83.8%
Dermata Therapeutics
Market Cap: US$4.7m
A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases.
DRMA
US$1.17
7D
-7.1%
1Y
-79.4%
Context Therapeutics
Market Cap: US$63.3m
A biopharmaceutical company, develops products for the treatment of solid tumors.
CNTX
US$0.84
7D
10.1%
1Y
-22.1%
Captor Capital
Market Cap: CA$3.1m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.89
7D
25.4%
1Y
-15.2%
Microbix Biosystems
Market Cap: CA$54.0m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.39
7D
2.7%
1Y
2.7%
Adverum Biotechnologies
Market Cap: US$95.9m
A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.
ADVM
US$4.73
7D
7.5%
1Y
-73.3%
Marker Therapeutics
Market Cap: US$13.2m
A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR
US$1.28
7D
-16.3%
1Y
-70.4%
BioRestorative Therapies
Market Cap: US$12.2m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.67
7D
8.4%
1Y
20.1%
Nykode Therapeutics
Market Cap: NOK 740.6m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.
NYKD
NOK 2.27
7D
12.3%
1Y
-84.0%
Poolbeg Pharma
Market Cap: UK£14.3m
Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.
POLB
UK£0.029
7D
-1.7%
1Y
-71.2%
Nanologica
Market Cap: SEK 148.9m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.
NICA
SEK 1.69
7D
1.8%
1Y
-74.1%
AC Immune
Market Cap: US$226.6m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.21
7D
-7.7%
1Y
-36.9%
Gossamer Bio
Market Cap: US$328.6m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$1.39
7D
20.9%
1Y
0.7%
Nuvation Bio
Market Cap: US$724.8m
A clinical-stage biopharmaceutical company, focuses on unmet needs in oncology by developing differentiated and novel therapeutic candidates.
NUVB
US$2.09
7D
11.2%
1Y
-7.5%
ProPhase Labs
Market Cap: US$11.9m
Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
PRPH
US$0.39
7D
3.6%
1Y
-92.3%
Skye Bioscience
Market Cap: US$75.8m
A biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of molecules that modulate G-protein coupled receptors.
SKYE
US$2.53
7D
-0.4%
1Y
-81.3%
AroCell
Market Cap: SEK 117.5m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
AROC
SEK 0.51
7D
1.0%
1Y
43.7%
Opus Genetics
Market Cap: US$29.5m
A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders.
IRD
US$0.94
7D
1.3%
1Y
-51.2%
BioCardia
Market Cap: US$11.9m
A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BCDA
US$2.62
7D
3.1%
1Y
-54.8%
Sera Prognostics
Market Cap: US$142.4m
A women’s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States.
SERA
US$4.14
7D
0%
1Y
-53.8%
Moleculin Biotech
Market Cap: US$3.4m
A clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses.
MBRX
US$1.13
7D
-1.7%
1Y
-86.3%
Ovoca Bio
Market Cap: €856.4k
A clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health.
OVXA
€0.011
7D
0%
1Y
110.0%
Valbiotis
Market Cap: €17.5m
Engages in the research and development of health nutrition products to prevent and control metabolic and cardiovascular diseases in France.
ALVAL
€1.11
7D
3.2%
1Y
-71.1%
Sensei Biotherapeutics
Market Cap: US$11.3m
An immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$0.44
7D
3.8%
1Y
-58.1%
Werewolf Therapeutics
Market Cap: US$53.8m
A biopharmaceutical company, develops therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
HOWL
US$1.17
7D
-4.5%
1Y
-80.6%
Biomea Fusion
Market Cap: US$92.0m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.
BMEA
US$2.52
7D
0.6%
1Y
-84.0%
Prime Medicine
Market Cap: US$228.5m
A biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology.
PRME
US$1.75
7D
-15.9%
1Y
-75.1%
Acelyrin
Market Cap: US$276.9m
A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
SLRN
US$2.75
7D
5.6%
1Y
-63.9%
AIM Vaccine
Market Cap: HK$4.7b
Researches, develops, manufactures, and commercializes of vaccine products for human use in the People’s Republic of China.
6660
HK$3.91
7D
-4.6%
1Y
-54.1%
PYC Therapeutics
Market Cap: AU$545.9m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.17
7D
-6.4%
1Y
46.3%
Intervacc
Market Cap: SEK 325.5m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 0.95
7D
-6.4%
1Y
-73.2%
TNF Pharmaceuticals
Market Cap: US$1.0m
A clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.
TNFA
US$0.39
7D
9.0%
1Y
-86.3%
Stem Cells Spin
Market Cap: zł7.8m
Operates as a biotechnology company in Poland.
SCS
zł0.19
7D
-2.6%
1Y
-67.4%
Aprea Therapeutics
Market Cap: US$13.0m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$2.34
7D
4.9%
1Y
-64.3%
Pliant Therapeutics
Market Cap: US$94.3m
A clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States.
PLRX
US$1.70
7D
18.9%
1Y
-88.4%